Bibliografia
Firenzuoli, F., Epifani, F., Loiacono I. (2015). Cannabis “Erba” Medica. Milano: Edra
Fortuna, L. (2006). Aromaterapia Naturopatica. Milano: Edizioni Enea
McKenna, J. (2000). Le Alternative ai Tranquillanti. Milano: tecniche Nuove
Scrimali, T. (2020). NegEnt: A cannabidiolo-based, herbal medicine. Theoretical aspects, pharmacology, clinical and research perspectives, economical and social implications. International Journal of Herbal Medicine, 8 (5): 143-151. Consultabile e scaricabile cliccando qui.
Baban, C., Khodadadi, K., Salles, EL, Costigliola, V., Yu, JC (2021). Inflammaging and Cannabinoids. Ageing Res. Rev., Ageing Research Reviews 72(1):101487 DOI: 10.1016/j.arr.2021.101487.
Bielawiec, P., Harasim-Symbor, E., Chabowski, A. (2020). Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol. Front Endocrinol (Lausanne), 4; 11:114. Doi: 10.3389/fendo.2020.00114.
Bonaccorso, S., Ricciardi A., Zangani C., Chiappini C., Schifano, F. (2019). Cannabidiol (CBD) use in psychiatric disorders: A systematic review. Neurotoxicology, Sep; 74: 282-298. Doi: 10.1016/j.neuro.2019.08.002.
Cooke, B., Ernst, E. (2000) Aromatherapy: a systematic review. Br J Gen Pract., Jun;50(455):493-6.
Della Rocca, G., Di Salvo, A. (2020). Hemp in Veterinary Medicine: From Feed to Drug. Front Vet Sci, Jul 28;7:387. Doi: 10.3389/fvets.2020.00387.
Firenzuoli, F., Epifani, F., Loiacono I. (2015). Medical “Weed” Cannabis. Milan: Edra.
Fortuna, L. (2006). Naturopathic Aromatherapy. Milan: Enea Editions.
Gattefossé, RM (1937). Aromathérapie – les huiles essentielles hormones végétales. Paris: Librairie des Sciences Girardot.
Kasman, A.M., Hriday P., Bhambhvani, H.P., Wilson-King, G., Michael L. Eisenberg, M.L. (2020). Sexual Medicine 8 (4). Doi:10.1016/j.esxm.2020.06.009.
Koo, M. (2017). A bibliometric analysis of two decades of aromatherapy research. Published online 2017, Jan 18.
Martin, L.J., Banister, S.D., Bowen, M.T. (2021). Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol. Pharmacological Research, Volume 166, April 2021, 105508.
McKenna, J. (2000). Alternatives to Tranquilisers. Milan: New Techniques.
Nagarkatti P., Pandey, R., Rieder S.A., Hegde VL, Nagarkatti M.(2009). Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem., 1:1333-49.
Nguyen, L.C., Yang, D., Nicolaescu, V. (2022). Cannabidiol inhibits Sars-Cov-2 replication though induction of the host ER stress and innate immune response. Sciences Advances, Volume 8, Issue 8.
Nichols, J.M., Kaplan, B.L.F. (2020). Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res, Feb 27;5(1):12-31. Doi: 10.1089/can.2018.0073.
Perry, N., Perry, E. (2006). Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives. CNS Drugs, Vol. 20, Issue 4.
Peyravian, N., Deo, S., Daunert, S, Jimenez, J-J. (2020). Cannabidiol as a Novel Therapeutic for Immune Modulation. Immunotargets Ther., Aug 18, 9: 131-140. Doi: 10.2147/ITT.S263690.
Price, S. Price, L. (2012). Aromatherapy for Health Professional. London: Elsevier.
Rojas-Valverde, D. (2021). Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. Front Physiol, Aug 3;12:722550. Doi: 10.3389/fphys.2021.722550.
Scrimali, T (2008). Entropy of Mind and Negative Entropy a Cognitive and Complex Approach to Schizophrenia and its Therapy. London: Karnac Books.
Scrimali, T. (2020). NegEnt: A cannabidiol-based, herbal medicine. Theoretical aspects, pharmacology, clinical and research perspectives, economical and social implications. International Journal of Herbal Medicine, 8 (5): 143-151.
Scrimali, T. (2022). NegEnt: Cannabidiolo Liposomiale in Medicina Umana e Veterinaria. Enna: Edizioni ALETEIA Publisher. Su Amazon Libri
Sheriff, T. Lin, M-J., Dubin, D., Khorasani, H. (2020). The potential role of cannabinoids in dermatology. J. Dermatolog. Treat., Dec; 31(8): 839-845. Doi: 10.1080/09546634.2019.1675854.
Stanley, C.P., Hind, W.H., O’Sullivan, S.O.(2013). Is the cardiovascular system a therapeutic target for cannabidiol? Br J Clin Pharmacol, Feb;75(2):313-22. Doi: 10.1111/j.1365-2125.2012.04351.x.
Vasudevan K, Stahl V. Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of total-culturable bacterial content in dental plaque samples. J Cannabis Res. 2020;2(1):20. doi:10.1186/s42238-020-00027-z.
WHO, (2018). CANNABIDIOL (CBD) Critical Review Report. Expert Committee on Drug Dependence, Fortieth Meeting, Geneva, 4-7 June 2018.
Cannabidiolo, NegEnt e Disturbo di Panico
Cannabidiolo e NegEnt per Dormire Bene e Risolvere l’Insonnia
Assegnato il Premio Efesto al Prof. Tullio Scrimali per lo sviluppo di NegEnt e le ricerche svolte su questo nuovo presidio terapeutico, da lui sviluppato
NegEnt sul quotidiano "La Sicilia"
